Literature DB >> 23017337

A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.

Sébastien Lyonnais1, Robert J Gorelick, Fatima Heniche-Boukhalfa, Serge Bouaziz, Vincent Parissi, Jean-François Mouscadet, Tobias Restle, Jose Maria Gatell, Eric Le Cam, Gilles Mirambeau.   

Abstract

HIV-1 reverse transcription is achieved in the newly infected cell before viral DNA (vDNA) nuclear import. Reverse transcriptase (RT) has previously been shown to function as a molecular motor, dismantling the nucleocapsid complex that binds the viral genome as soon as plus-strand DNA synthesis initiates. We first propose a detailed model of this dismantling in close relationship with the sequential conversion from RNA to double-stranded (ds) DNA, focusing on the nucleocapsid protein (NCp7). The HIV-1 DNA-containing pre-integration complex (PIC) resulting from completion of reverse transcription is translocated through the nuclear pore. The PIC nucleoprotein architecture is poorly understood but contains at least two HIV-1 proteins initially from the virion core, namely integrase (IN) and the viral protein r (Vpr). We next present a set of electron micrographs supporting that Vpr behaves as a DNA architectural protein, initiating multiple DNA bridges over more than 500 base pairs (bp). These complexes are shown to interact with NCp7 bound to single-stranded nucleic acid regions that are thought to maintain IN binding during dsDNA synthesis, concurrently with nucleocapsid complex dismantling. This unexpected binding of Vpr conveniently leads to a compacted but filamentous folding of the vDNA that should favor its nuclear import. Finally, nucleocapsid-like aggregates engaged in dsDNA synthesis appear to efficiently bind to F-actin filaments, a property that may be involved in targeting complexes to the nuclear envelope. More generally, this article highlights unique possibilities offered by in vitro reconstitution approaches combined with macromolecular imaging to gain insights into the mechanisms that alter the nucleoprotein architecture of the HIV-1 genome, ultimately enabling its insertion into the nuclear chromatin.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23017337      PMCID: PMC3552025          DOI: 10.1016/j.virusres.2012.09.008

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  147 in total

1.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 2.  Cellular magnesium homeostasis.

Authors:  Andrea M P Romani
Journal:  Arch Biochem Biophys       Date:  2011-05-27       Impact factor: 4.013

3.  The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes.

Authors:  Chou-Wen Lin; Alan Engelman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase.

Authors:  P Levy-Mintz; L Duan; H Zhang; B Hu; G Dornadula; M Zhu; J Kulkosky; D Bizub-Bender; A M Skalka; R J Pomerantz
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Nucleoprotein intermediates in HIV-1 DNA integration visualized by atomic force microscopy.

Authors:  Svetlana Kotova; Min Li; Emilios K Dimitriadis; Robert Craigie
Journal:  J Mol Biol       Date:  2010-04-21       Impact factor: 5.469

6.  Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.

Authors:  Erwann Le Rouzic; Aurélie Mousnier; Cecilia Rustum; Françoise Stutz; Einar Hallberg; Catherine Dargemont; Serge Benichou
Journal:  J Biol Chem       Date:  2002-09-12       Impact factor: 5.157

7.  Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid.

Authors:  Sergei Popov; Elena Popova; Michio Inoue; Heinrich G Göttlinger
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

8.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

9.  The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains.

Authors:  Sara M Ø Solbak; Victor Wray; Ole Horvli; Arnt J Raae; Marte I Flydal; Petra Henklein; Peter Henklein; Manfred Nimtz; Ulrich Schubert; Torgils Fossen
Journal:  BMC Struct Biol       Date:  2011-12-20

10.  Circularization of the HIV-1 RNA genome.

Authors:  Marcel Ooms; Truus E M Abbink; Chi Pham; Ben Berkhout
Journal:  Nucleic Acids Res       Date:  2007-08-07       Impact factor: 16.971

View more
  17 in total

1.  An HIV-1 replication pathway utilizing reverse transcription products that fail to integrate.

Authors:  Benjamin Trinité; Eric C Ohlson; Igor Voznesensky; Shashank P Rana; Chi N Chan; Saurabh Mahajan; Jason Alster; Sean A Burke; Dominik Wodarz; David N Levy
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

2.  Selection of fully processed HIV-1 nucleocapsid protein is required for optimal nucleic acid chaperone activity in reverse transcription.

Authors:  Tiyun Wu; Robert J Gorelick; Judith G Levin
Journal:  Virus Res       Date:  2014-06-20       Impact factor: 3.303

3.  Distribution and Redistribution of HIV-1 Nucleocapsid Protein in Immature, Mature, and Integrase-Inhibited Virions: a Role for Integrase in Maturation.

Authors:  Juan Fontana; Kellie A Jurado; Naiqian Cheng; Ngoc L Ly; James R Fuchs; Robert J Gorelick; Alan N Engelman; Alasdair C Steven
Journal:  J Virol       Date:  2015-07-15       Impact factor: 5.103

Review 4.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

5.  Investigating the cellular distribution and interactions of HIV-1 nucleocapsid protein by quantitative fluorescence microscopy.

Authors:  Halina Anton; Nedal Taha; Emmanuel Boutant; Ludovic Richert; Heena Khatter; Bruno Klaholz; Philippe Rondé; Eléonore Réal; Hugues de Rocquigny; Yves Mély
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

6.  Dynamic interactions of the HIV-1 Tat with nucleic acids are critical for Tat activity in reverse transcription.

Authors:  Christian Boudier; Nicolas Humbert; Françoise Chaminade; Yingying Chen; Hugues de Rocquigny; Julien Godet; Olivier Mauffret; Philippe Fossé; Yves Mély
Journal:  Nucleic Acids Res       Date:  2013-10-22       Impact factor: 16.971

7.  An Infectious Rous Sarcoma Virus Gag Mutant That Is Defective in Nuclear Cycling.

Authors:  Clifton L Ricaña; Marc C Johnson
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

Review 8.  HIV-1 Vpr-a still "enigmatic multitasker".

Authors:  Carolin A Guenzel; Cécile Hérate; Serge Benichou
Journal:  Front Microbiol       Date:  2014-03-31       Impact factor: 5.640

9.  The human antiviral factor TRIM11 is under the regulation of HIV-1 Vpr.

Authors:  Ting Yuan; Weitong Yao; Fang Huang; Binlian Sun; Rongge Yang
Journal:  PLoS One       Date:  2014-08-08       Impact factor: 3.240

10.  HIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus.

Authors:  Célia Chamontin; Patrice Rassam; Mireia Ferrer; Pierre-Jean Racine; Aymeric Neyret; Sébastien Lainé; Pierre-Emmanuel Milhiet; Marylène Mougel
Journal:  Nucleic Acids Res       Date:  2014-12-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.